NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Rachel S Heise
Cornell University - Ithaca / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 5185868
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Rachel S Heise's MOST POPULAR ARTICLES
1-)
Coronary artery bypass graft failure in women: incidence and clinical implicationsS Sandner, B Redfors, KR An, L Harik, R Heise, A Di Franco, SE Fremes, ...Journal of the American College of Cardiology 84 (2), 182-191, 2024
2-)
SU2C-SARC032: A randomized trial of neoadjuvant RT and surgery with or without pembrolizumab for soft tissue sarcoma.YM Mowery, KV Ballman, AM Hong, S Schuetze, AJ Wagner, V Monga, ...Journal of Clinical Oncology 42 (16_suppl), 11504-11504, 2024
3-)
SARC037: Results of phase I study of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in relapsed/refractory Ewing sarcoma (ES).P Grohar, KV Ballman, R Heise, J Glod, MF Wedekind, L Mascarenhas, ...Journal of Clinical Oncology 41 (16_suppl), 11519-11519, 2023
4-)
Development and testing of a polygenic risk score for breast cancer aggressivenessY Shieh, J Roger, C Yau, DM Wolf, GL Hirst, LB Swigart, S Huntsman, ...NPJ Precision Oncology 7 (1), 42, 2023
5-)
A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid HemangioendotheliomaSM Schuetze, KV Ballman, R Heise, KN Ganjoo, EJ Davis, S George, ...Clinical Cancer Research 30 (20), 4584-4592, 2024
ARTICLES
Add your articles
Request Your Free Demo
Country *
Institution Name *
Name Surname *
E-Mail Address *
Job Title *
Description
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept